by Jessica Casebolt | Mar 15, 2023 | D.C. News, Tea Leaves
The Biden administration will fine manufacturers who hiked prices for 27 medicines faster than the rate of inflation. Pfizer had five drugs on the list, the most of any manufacturer. AbbVie’s blockbuster arthritis drug, Humira, was also on the list. Officials said the...
by Jessica Casebolt | Mar 15, 2023 | Access & Coverage, Tea Leaves
Yesterday, fourteen Democratic governors asked seven leading pharmacy retailers to clarify their plans for dispensing mifepristone, a pill used in medication abortions. The move comes shortly after Walgreens announced that it would not dispense mifepristone in some...
by Jessica Casebolt | Mar 14, 2023 | Public Health/Prevention, Tea Leaves
President Biden is expected to sign an executive order today that would increase the number of background checks to buy guns, promote better and more secure firearms storage, and ensure U.S. law enforcement agencies are getting the most out of a bipartisan gun control...
by Jessica Casebolt | Mar 14, 2023 | Payers, Tea Leaves
Thousands of patients have called on a federal court to reverse a landmark ruling allowing a UnitedHealth Group subsidiary to develop mental and substance abuse coverage guidelines they allege deviate from clinical standards. The American Medical Association, the...
by Jessica Casebolt | Mar 14, 2023 | Access & Coverage, Tea Leaves
The Veterans Health Administration (VHA) announced yesterday that it intends to pay for the experimental Alzheimer’s drug, Leqembi, that the Centers for Medicare and Medicaid Services has to date declined to cover. The decision by VHA stands in contrast with...
by Jessica Casebolt | Mar 13, 2023 | Life Sciences, Tea Leaves
Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. A study published in the New England Journal of Medicine directly compared the three approaches of surgery to remove...
Recent Comments